Hydroxymethylnicotinamide

羟甲基烟酰胺

Report date: 2023/03/13 20:00:38
NME

Base Information

Drug NameHydroxymethylnicotinamide
Drug Alias Name羟甲烟胺氧甲盐酸胺
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsCholecystitisGallbladder DiseasesCholangitis +[4] 
Global Approved IndicationsCholecystitisCholangitisHepatitis, Viral, Human
Approved Indications in ChinaCholecystitisCholangitisHepatitis, Viral, Human
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Shenhua Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCholecystitisGallbladder DiseasesCholangitis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeA05AB01
Related LinksKEGG